Patents by Inventor Jeffrey H. Lawson

Jeffrey H. Lawson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938260
    Abstract: An apparatus for guiding cannulation with a dialysis needle of an arteriovenous dialysis access graft subcutaneously implanted in a body of a subject. The guiding apparatus comprises an elongated body member comprising a base portion terminating in longitudinal edges, a distance between the longitudinal edges of the base portion being substantially equal to a lateral dimension of the aces graft, and an elongated tubular sleeve defining an pocket having a longitudinal dimension and a lateral dimension configured to receive the body member. The body member is adapted to be received in the pocket of the sleeve for securing adjacent the subcutaneous access graft such that the inner surface of the base portion is aligned with a cannulation point of the graft for guiding location of a needle insertion.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: March 26, 2024
    Assignee: InnAVasc Medical, Inc.
    Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
  • Publication number: 20230043946
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit from the first end portion to the second end portion; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet at a first end thereof and an outlet at a second, opposed end thereof, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; a self-sealing material extending across the cannulation port; and a longitudinal passageway defined by the housing and the self-sealing material that extends from the inlet to the outlet of the housing.
    Type: Application
    Filed: October 20, 2022
    Publication date: February 9, 2023
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Patent number: 11504461
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: November 22, 2022
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Publication number: 20210346585
    Abstract: An apparatus for guiding cannulation with a dialysis needle of an arteriovenous dialysis access graft subcutaneously implanted in a body of a subject. The guiding apparatus comprises an elongated body member comprising a base portion terminating in longitudinal edges, a distance between the longitudinal edges of the base portion being substantially equal to a lateral dimension of the aces graft, and an elongated tubular sleeve defining an pocket having a longitudinal dimension and a lateral dimension configured to receive the body member. The body member is adapted to be received in the pocket of the sleeve for securing adjacent the subcutaneous access graft such that the inner surface of the base portion is aligned with a cannulation point of the graft for guiding location of a needle insertion.
    Type: Application
    Filed: July 19, 2021
    Publication date: November 11, 2021
    Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
  • Patent number: 11065377
    Abstract: An apparatus for guiding cannulation with a dialysis needle of an arteriovenous dialysis access graft subcutaneously implanted in a body of a subject. The guiding apparatus comprises an elongated body member comprising a base portion terminating in longitudinal edges, a distance between the longitudinal edges of the base portion being substantially equal to a lateral dimension of the aces graft, and an elongated tubular sleeve defining an pocket having a longitudinal dimension and a lateral dimension configured to receive the body member. The body member is adapted to be received in the pocket of the sleeve for securing adjacent the subcutaneous access graft such that the inner surface of the base portion is aligned with a cannulation point of the graft for guiding location of a needle insertion.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: July 20, 2021
    Assignee: InnAVasc Medical, Inc.
    Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
  • Publication number: 20200016320
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 16, 2020
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Patent number: 10420874
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: September 24, 2019
    Assignee: Duke University
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Publication number: 20180289883
    Abstract: An apparatus for guiding cannulation with a dialysis needle of an arteriovenous dialysis access graft subcutaneously implanted in a body of a subject. The guiding apparatus comprises an elongated body member comprising a base portion terminating in longitudinal edges, a distance between the longitudinal edges of the base portion being substantially equal to a lateral dimension of the aces graft, and an elongated tubular sleeve defining an pocket having a longitudinal dimension and a lateral dimension configured to receive the body member. The body member is adapted to be received in the pocket of the sleeve for securing adjacent the subcutaneous access graft such that the inner surface of the base portion is aligned with a cannulation point of the graft for guiding location of a needle insertion.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 11, 2018
    Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
  • Publication number: 20180280605
    Abstract: An arteriovenous dialysis access graft is configured to be implanted in a body of a subject. The arteriovenous dialysis graft comprises a flexible conduit defining a longitudinal flow passageway. The conduit has a first end portion and a second end portion, the first end portion configured to connect to an artery of the subject and the second end portion configured to connect to a vein of the subject such that blood flows through the longitudinal flow passageway of the conduit from the first end portion to the second end portion. The graft further comprises a first cannulation chamber and a spaced second cannulation chamber with the conduit extending through each of the first chamber and the second chamber. The first chamber is positioned between the first end portion and the second chamber, and the second chamber is positioned between the second end portion and the first chamber. A valve device is positioned between the first cannulation chamber and the second cannulation chamber for controlling fluid flow.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 4, 2018
    Inventors: Shawn M. Gage, Jeffrey H. Lawson, Joseph Knight, Craig Nichols
  • Publication number: 20170173252
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
    Type: Application
    Filed: March 6, 2017
    Publication date: June 22, 2017
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Patent number: 9585998
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: March 7, 2017
    Assignee: Duke University
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Publication number: 20140018721
    Abstract: An arteriovenous dialysis access graft configured to be implanted in a subject includes: at least one flexible conduit having first and second end portions, wherein the first end portion is configured to connect to an artery of the subject and the second end portion is configured to connect to a vein of the subject such that blood flows through the at least one conduit; and at least one cannulation chamber positioned between the first end portion and the second end portion of the at least one conduit. The chamber includes: an elongated housing having an inlet and an outlet, a posterior wall, a pair of sidewalls, and an open anterior portion defining a cannulation port; and a self-sealing material extending across the cannulation port. The posterior wall and the sidewalls of the housing are formed of a substantially rigid material.
    Type: Application
    Filed: September 16, 2013
    Publication date: January 16, 2014
    Applicant: Duke University
    Inventors: Shawn M. Gage, Jeffrey H. Lawson
  • Publication number: 20030125254
    Abstract: The present invention relates, in general, to vascular smooth muscle proliferation and, in particular, to a method of inhibiting arterial and venous smooth muscle proliferation resulting, for example, from arterial injury, vein grafting or shunt implantation. The invention also relates to an expression construct encoding a G&bgr;&ggr; inhibitor suitable for use in such a method.
    Type: Application
    Filed: October 2, 2002
    Publication date: July 3, 2003
    Applicant: DUKE UNIVERSITY
    Inventors: Walter J. Koch, Jeffrey H. Lawson
  • Patent number: 5399487
    Abstract: The present invention encompasses compounds of formula I: ##STR1## and the pharmaceutically acceptable non-toxic salts thereof; wherein R.sub.1 is hydrogen, lower alkyl, alkenyl, alkynyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, or phenylalkyl;R.sub.2 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, or phenylalkyl; orNR.sub.1 R.sub.2 forms a nitrogen heterocycle; andR.sub.3 is hydrogen, an amino acid or a peptide residue.These compounds may be employed as substrates in assays for determining proteolytic enzyme activity or as enzyme inhibitors. The invention also encompasses methods for determining proteolytic enzyme activity using the compounds of formula I.
    Type: Grant
    Filed: March 4, 1993
    Date of Patent: March 21, 1995
    Assignee: Haematologic Technologies, Inc.
    Inventors: Saulius Butenas, Jeffrey H. Lawson, Kenneth G. Mann